Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 751

1.

Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: The PROSE study population.

Augustin M, Dauden E, Mrowietz U, Konstantinou MP, Gerdes S, Rissler M, Gathmann S, Sieder C, Baeumer D, Orsenigo R.

J Eur Acad Dermatol Venereol. 2020 Apr 2. doi: 10.1111/jdv.16400. [Epub ahead of print]

PMID:
32239541
2.

Free carnitine and branched chain amino acids are not good biomarkers in Huntington's disease.

Castilhos RM, Augustin MC, Santos JAD, Pedroso JL, Barsottini O, Saba R, Ferraz HB, Vargas FR, Furtado GV, Polese-Bonatto M, Rodrigues LP, Sena LS, Vargas CR, Saraiva-Pereira ML, Jardim LB, Neurogenética R.

Arq Neuropsiquiatr. 2020 Feb;78(2):81-87. doi: 10.1590/0004-282X20190152.

3.

Influence of human wound exudate on the bactericidal efficacy of antiseptic agents in quantitative suspension tests on the basis of European Standards (DIN EN 13727).

Radischat N, Augustin M, Herberger K, Wille A, Goroncy-Bermes P.

Int Wound J. 2020 Mar 5. doi: 10.1111/iwj.13336. [Epub ahead of print]

PMID:
32133774
4.

Discovery of sulfonamides and 9-oxo-2,8-diazaspiro[5,5]undecane-2-carboxamides as human kynurenine aminotransferase 2 (KAT2) inhibitors.

Kalliokoski T, Rummakko P, Rantanen M, Blaesse M, Augustin M, Ummenthala GR, Choudhary S, Venäläinen J.

Bioorg Med Chem Lett. 2020 Apr 15;30(8):127060. doi: 10.1016/j.bmcl.2020.127060. Epub 2020 Feb 22.

PMID:
32113843
5.

Economic evaluation of a tertiary prevention program for occupational skin diseases in Germany.

Andrees V, John SM, Nienhaus A, Skudlik C, Brans R, Augustin M, Krensel M; ROQ-Study group.

Contact Dermatitis. 2020 Feb 25. doi: 10.1111/cod.13506. [Epub ahead of print]

PMID:
32100302
6.

Changes in Retinal Blood Flow in Response to an Experimental Increase in IOP in Healthy Participants as Assessed With Doppler Optical Coherence Tomography.

Puchner S, Schmidl D, Ginner L, Augustin M, Leitgeb R, Szegedi S, Stjepanek K, Hommer N, Kallab M, Werkmeister RM, Schmetterer L, Garhofer G.

Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):33. doi: 10.1167/iovs.61.2.33.

PMID:
32084274
7.

Implementation of dupilumab in routine care of atopic eczema. Results from the German national registry TREATgermany.

Abraham S, Haufe E, Harder I, Heratizadeh A, Kleinheinz A, Wollenberg A, Weisshaar E, Augustin M, Wiemers F, Zink A, Biedermann T, von Kiedrowski R, Hilgers M, Worm M, Pawlak M, Sticherling M, Fell I, Handrick C, Schäkel K, Staubach P, Asmussen A, Schwarz B, Bell M, Neubert K, Effendy I, Bieber T, Homey B, Gerlach B, Tchitcherina E, Stahl M, Schwichtenberg U, Rossbacher J, Buck P, Mempel M, Beissert S, Werfel T, Weidinger S, Schmitt J; TREATgermany study group.

Br J Dermatol. 2020 Feb 18. doi: 10.1111/bjd.18958. [Epub ahead of print]

PMID:
32068242
8.

Efficacy of MMP-inhibiting wound dressings in the treatment of chronic wounds: a systematic review.

Dissemond J, Augustin M, Dietlein M, Faust U, Keuthage W, Lobmann R, Münter KC, Strohal R, Stücker M, Traber J, Vanscheidt W, Läuchli S.

J Wound Care. 2020 Feb 2;29(2):102-118. doi: 10.12968/jowc.2020.29.2.102.

PMID:
32058850
9.

Pregnancy exposure to venlafaxine-Therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomes.

Paulzen M, Schoretsanitis G, Gründer G, Franz C, Stingl JC, Augustin M.

J Affect Disord. 2020 Apr 1;266:578-584. doi: 10.1016/j.jad.2020.02.010. Epub 2020 Feb 3.

PMID:
32056930
10.

Retinal analysis of a mouse model of Alzheimer's disease with multicontrast optical coherence tomography.

Harper DJ, Augustin M, Lichtenegger A, Gesperger J, Himmel T, Muck M, Merkle CW, Eugui P, Kummer S, Woehrer A, Glösmann M, Baumann B.

Neurophotonics. 2020 Jan;7(1):015006. doi: 10.1117/1.NPh.7.1.015006. Epub 2020 Feb 4.

11.

Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis.

Armstrong AW, Puig L, Joshi A, Skup M, Williams D, Li J, Betts KA, Augustin M.

JAMA Dermatol. 2020 Feb 5. doi: 10.1001/jamadermatol.2019.4029. [Epub ahead of print]

PMID:
32022825
12.

Regional variations in the use of statutory skin cancer screenings in Germany: Population-based spatial multisource analysis.

Augustin J, Sorbe C, Augustin M, Zander N, Kis A.

J Eur Acad Dermatol Venereol. 2020 Jan 25. doi: 10.1111/jdv.16228. [Epub ahead of print]

PMID:
31981431
13.

Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany.

Runge M, Krensel M, Westermann C, Bindl D, Nagels K, Augustin M, Nienhaus A.

Int J Environ Res Public Health. 2020 Jan 9;17(2). pii: E440. doi: 10.3390/ijerph17020440.

14.

Mild heat combined with lactic acid fermentation: a novel approach for enhancing sulforaphane yield in broccoli puree.

Cai YX, Augustin MA, Jegasothy H, Wang JH, Terefe NS.

Food Funct. 2020 Jan 29;11(1):779-786. doi: 10.1039/c9fo02089f.

PMID:
31922158
15.

Real-world evidence of secukinumab in psoriasis treatment - a meta-analysis of 43 studies.

Augustin M, Jullien D, Martin A, Peralta C.

J Eur Acad Dermatol Venereol. 2020 Jan 9. doi: 10.1111/jdv.16180. [Epub ahead of print] Review.

PMID:
31919937
16.

Mean Platelet Volume Does Not Predict Restenosis After Carotid Artery Stenting in Whites.

Haidegger M, Kneihsl M, Niederkorn K, Deutschmann H, Augustin M, Wünsch G, Fandler-Höfler S, Horner S, Fazekas F, Enzinger C, Gattringer T.

Stroke. 2020 Mar;51(3):986-989. doi: 10.1161/STROKEAHA.119.028180. Epub 2019 Dec 18.

PMID:
31847751
17.

Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcers.

Lobmann R, Augustin M, Lawall H, Tigges W, Potempa C, Thiem H, Fietz C, Rychlik RP.

J Wound Care. 2019 Dec 2;28(12):808-816. doi: 10.12968/jowc.2019.28.12.808.

PMID:
31825772
18.

Signal averaging improves signal-to-noise in OCT images: But which approach works best, and when?

Baumann B, Merkle CW, Leitgeb RA, Augustin M, Wartak A, Pircher M, Hitzenberger CK.

Biomed Opt Express. 2019 Oct 17;10(11):5755-5775. doi: 10.1364/BOE.10.005755. eCollection 2019 Nov 1.

19.

Influence of Kidney Function on Serum Risperidone Concentrations in Patients Treated With Risperidone.

Gründer P, Augustin M, Paulzen M, Gründer G.

J Clin Psychiatry. 2019 Nov 26;80(6). pii: 19m12890. doi: 10.4088/JCP.19m12890.

PMID:
31774943
20.

Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors.

Zhou H, McGowan MA, Lipford K, Christopher M, Fradera X, Witter D, Lesburg CA, Li C, Methot JL, Lampe J, Achab A, Shaffer L, Goldenblatt P, Shah S, Bass A, Schroeder G, Chen D, Zeng H, Augustin MA, Katz JD.

Bioorg Med Chem Lett. 2020 Jan 1;30(1):126715. doi: 10.1016/j.bmcl.2019.126715. Epub 2019 Oct 18.

PMID:
31757666
21.

Recall of health-related quality of life: how does memory affect the SF-6D in patients with psoriasis or multiple sclerosis? A prospective observational study in Germany.

Topp J, Andrees V, Heesen C, Augustin M, Blome C.

BMJ Open. 2019 Nov 21;9(11):e032859. doi: 10.1136/bmjopen-2019-032859.

22.

Diagnosis and treatment of xerosis cutis - a position paper.

Augustin M, Wilsmann-Theis D, Körber A, Kerscher M, Itschert G, Dippel M, Staubach P.

J Dtsch Dermatol Ges. 2019 Nov;17 Suppl 7:3-33. doi: 10.1111/ddg.13906.

PMID:
31738016
23.

Recurrent eczema herpeticum - a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients.

Seegräber M, Worm M, Werfel T, Svensson A, Novak N, Simon D, Darsow U, Augustin M, Wollenberg A.

J Eur Acad Dermatol Venereol. 2019 Nov 16. doi: 10.1111/jdv.16090. [Epub ahead of print]

PMID:
31733162
24.

Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany.

Heratizadeh A, Haufe E, Stölzl D, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, Weisshaar E, Augustin M, Wiemers F, Zink A, von Kiedrowski R, Hilgers M, Worm M, Pawlak M, Sticherling M, Fell I, Handrick C, Schäkel K, Staubach-Renz P, Asmussen A, Schwarz B, Bell M, Effendy I, Bieber T, Homey B, Gerlach B, Tchitcherina E, Stahl M, Schwichtenberg U, Rossbacher J, Buck P, Mempel M, Beissert S, Biedermann T, Weidinger S, Schmitt J, Werfel T; TREATgermany Study Group.

J Eur Acad Dermatol Venereol. 2019 Nov 13. doi: 10.1111/jdv.16078. [Epub ahead of print]

PMID:
31721316
25.

How should electronic health records be designed? A cross-sectional study in patients with psoriasis.

Klein TM, Augustin M, Otten M.

BMC Med Inform Decis Mak. 2019 Nov 12;19(1):218. doi: 10.1186/s12911-019-0926-5.

26.

Live interactive teledermatology compared to in-person care - a systematic review.

Andrees V, Klein TM, Augustin M, Otten M.

J Eur Acad Dermatol Venereol. 2020 Apr;34(4):733-745. doi: 10.1111/jdv.16070. Epub 2020 Jan 29. Review.

PMID:
31715035
27.

Disease burden and patient needs and benefits in anogenital psoriasis: developmental specificities for person-centred healthcare of emerging adults and adults.

da Silva N, von Stülpnagel C, Langenbruch A, Danckworth A, Augustin M, Sommer R.

J Eur Acad Dermatol Venereol. 2019 Nov 12. doi: 10.1111/jdv.16076. [Epub ahead of print]

PMID:
31715033
28.

Rationale and Design of the Hamburg City Health Study.

Jagodzinski A, Johansen C, Koch-Gromus U, Aarabi G, Adam G, Anders S, Augustin M, der Kellen RB, Beikler T, Behrendt CA, Betz CS, Bokemeyer C, Borof K, Briken P, Busch CJ, Büchel C, Brassen S, Debus ES, Eggers L, Fiehler J, Gallinat J, Gellißen S, Gerloff C, Girdauskas E, Gosau M, Graefen M, Härter M, Harth V, Heidemann C, Heydecke G, Huber TB, Hussein Y, Kampf MO, von dem Knesebeck O, Konnopka A, König HH, Kromer R, Kubisch C, Kühn S, Loges S, Löwe B, Lund G, Meyer C, Nagel L, Nienhaus A, Pantel K, Petersen E, Püschel K, Reichenspurner H, Sauter G, Scherer M, Scherschel K, Schiffner U, Schnabel RB, Schulz H, Smeets R, Sokalskis V, Spitzer MS, Terschüren C, Thederan I, Thoma T, Thomalla G, Waschki B, Wegscheider K, Wenzel JP, Wiese S, Zyriax BC, Zeller T, Blankenberg S.

Eur J Epidemiol. 2019 Nov 8. doi: 10.1007/s10654-019-00577-4. [Epub ahead of print]

PMID:
31705407
29.

[Access to statutory skin cancer screening : Organizational and regional factors in Germany].

Andrees V, Girbig G, Krensel M, Augustin M, Zander N.

Hautarzt. 2020 Jan;71(1):39-45. doi: 10.1007/s00105-019-04494-1. German.

PMID:
31659389
30.

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.

Langley RGB, Reich K, Strand V, Feldman SR, Paul C, Gordon K, Warren RB, Toth D, Nikaï E, Zhu B, Goldblum O, Edson-Heredia E, Carlier H, Burge R, Lin CY, Hollister K, Augustin M.

Qual Life Res. 2020 Feb;29(2):369-380. doi: 10.1007/s11136-019-02296-5. Epub 2019 Oct 26.

PMID:
31655974
31.

[Predictors of Utilization of Cardiovascular and Respiratory Emergency Department Visits - what Impact does the Environment have?]

Krefis AC, Fischereit J, Hoffmann P, Sorbe C, Pinnschmidt H, Augustin M, Augustin J.

Gesundheitswesen. 2019 Oct 15. doi: 10.1055/a-1005-7161. [Epub ahead of print] German.

PMID:
31614385
32.

Fermentation for tailoring the technological and health related functionality of food products.

Shiferaw Terefe N, Augustin MA.

Crit Rev Food Sci Nutr. 2019 Oct 4:1-27. doi: 10.1080/10408398.2019.1666250. [Epub ahead of print]

PMID:
31583891
33.

Minimal Clinically Important Difference in Chronic Pruritus Appears to be Dependent on Baseline Itch Severity.

Riepe C, Osada N, Reich A, Augustin M, Zeidler C, Ständer S.

Acta Derm Venereol. 2019 Dec 1;99(13):1288-1290. doi: 10.2340/00015555-3332. No abstract available.

34.

Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry.

Cazzaniga S, Anzengruber F, Augustin M, Boehncke WH, Borradori L, Conrad C, Cozzio A, Djamei V, French LE, Gilliet M, Häusermann P, Heidemeyer K, Itin P, Kolios AGA, Laffitte E, Maul JT, Mainetti C, Naldi L, Navarini AA, Rustenbach SJ, Simon D, Sorbe C, Streit M, Yawalkar N.

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):2313-2318. doi: 10.1111/jdv.15983. Epub 2019 Oct 28.

PMID:
31562785
35.

An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12.

Papp K, Maari C, Cauthen A, Gooderham M, Spelman L, Yamanaka K, Polzer P, Zhang L, Osuntokun O, Augustin M.

Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18550. [Epub ahead of print]

PMID:
31545506
36.

Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study.

Thaçi D, Körber A, von Kiedrowski R, Bachhuber T, Melzer N, Kasparek T, Duetting E, Kraehn-Senftleben G, Amon U, Augustin M.

J Eur Acad Dermatol Venereol. 2020 Feb;34(2):310-318. doi: 10.1111/jdv.15962. Epub 2019 Oct 17.

PMID:
31541554
37.

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2.

Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M.

J Dtsch Dermatol Ges. 2019 Sep;17(9):959-974. doi: 10.1111/ddg.13936_g. German.

PMID:
31538739
38.

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2.

Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M.

J Dtsch Dermatol Ges. 2019 Sep;17(9):959-973. doi: 10.1111/ddg.13936.

PMID:
31538732
39.

Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach.

Kirsten N, Petersen J, Hagenström K, Augustin M.

J Eur Acad Dermatol Venereol. 2020 Jan;34(1):174-179. doi: 10.1111/jdv.15940. Epub 2019 Oct 8.

PMID:
31494987
40.

Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientation.

Augustin M, Langenbruch A, Blome C, Gutknecht M, Werfel T, Ständer S, Steinke S, Kirsten N, Silva N, Sommer R.

J Eur Acad Dermatol Venereol. 2020 Jan;34(1):142-152. doi: 10.1111/jdv.15919. Epub 2019 Nov 5.

PMID:
31465587
41.

Ultrahigh-current-density niobium disulfide catalysts for hydrogen evolution.

Yang J, Mohmad AR, Wang Y, Fullon R, Song X, Zhao F, Bozkurt I, Augustin M, Santos EJG, Shin HS, Zhang W, Voiry D, Jeong HY, Chhowalla M.

Nat Mater. 2019 Dec;18(12):1309-1314. doi: 10.1038/s41563-019-0463-8. Epub 2019 Aug 26.

PMID:
31451781
42.

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 1.

Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M.

J Dtsch Dermatol Ges. 2019 Aug;17(8):856-870. doi: 10.1111/ddg.13907_g. German.

PMID:
31437372
43.

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1.

Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schläger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M.

J Dtsch Dermatol Ges. 2019 Aug;17(8):856-870. doi: 10.1111/ddg.13907.

PMID:
31437363
44.

Education in people with venous leg ulcers based on a brochure about compression therapy: A quasi-randomised controlled trial.

Protz K, Dissemond J, Seifert M, Hintner M, Temme B, Verheyen-Cronau I, Augustin M, Otten M.

Int Wound J. 2019 Dec;16(6):1252-1262. doi: 10.1111/iwj.13172. Epub 2019 Aug 16.

PMID:
31418532
45.

Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow.

Fradera X, Methot JL, Achab A, Christopher M, Altman MD, Zhou H, McGowan MA, Kattar SD, Wilson K, Garcia Y, Augustin MA, Lesburg CA, Shah S, Goldenblatt P, Katz JD.

Bioorg Med Chem Lett. 2019 Sep 15;29(18):2575-2580. doi: 10.1016/j.bmcl.2019.08.004. Epub 2019 Aug 5.

PMID:
31416665
46.

Polarization-sensitive imaging with simultaneous bright- and dark-field optical coherence tomography.

Eugui P, Harper DJ, Lichtenegger A, Augustin M, Merkle CW, Woehrer A, Hitzenberger CK, Baumann B.

Opt Lett. 2019 Aug 15;44(16):4040-4043. doi: 10.1364/OL.44.004040.

PMID:
31415542
47.

Development of broccoli by-products as carriers for delivering EGCG.

Shi M, Ying DY, Hlaing MM, Ye JH, Sanguansri L, Augustin MA.

Food Chem. 2019 Dec 15;301:125301. doi: 10.1016/j.foodchem.2019.125301. Epub 2019 Jul 31.

PMID:
31387032
48.

Quality of Life in Psoriasis Vulgaris: Use of the ItchyQoL Question-naire in a Secukinumab Phase III Trial in Patients with Psoriasis Vulgaris.

Ständer S, Steinke S, Augustin M, Metze D, Loser K, Baeumer D, Sieder C, Luger T.

Acta Derm Venereol. 2019 Nov 1;99(12):1085-1090. doi: 10.2340/00015555-3275.

49.

A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment.

Reich K, Augustin M, Thaçi D, Pinter A, Leutz A, Henneges C, Schneider E, Schacht A, Dossenbach M, Mrowietz U.

Br J Dermatol. 2020 Apr;182(4):869-879. doi: 10.1111/bjd.18384. Epub 2019 Nov 19.

PMID:
31376153
50.

Hyperspectral optical coherence tomography for in vivo visualization of melanin in the retinal pigment epithelium.

Harper DJ, Konegger T, Augustin M, Schützenberger K, Eugui P, Lichtenegger A, Merkle CW, Hitzenberger CK, Glösmann M, Baumann B.

J Biophotonics. 2019 Dec;12(12):e201900153. doi: 10.1002/jbio.201900153. Epub 2019 Aug 13.

Supplemental Content

Loading ...
Support Center